Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma

AIM To analyze colorectal carcinogenesis and age-related DNA methylation alterations of gene sequences associated with epigenetic clock CpG sites. METHODS In silico DNA methylation analysis of 353 epigenetic clock CpG sites published by Steve Horvath was performed using methylation array data for a set of 123 colonic tissue samples [64 colorectal cancer (CRC), 42 adenoma, 17 normal; GEO accession number: GSE48684]. Among the differentially methylated age-related genes, secreted frizzled related protein 1 (SFRP1) promoter methylation was further investigated in colonic tissue from 8 healthy adults, 19 normal children, 20 adenoma and 8 CRC patients using bisulfite-specific PCR followed by methylation-specific high resolution melting (MS-HRM) analysis. mRNA expression of age-related “epigenetic clock” genes was studied using Affymetrix HGU133 Plus2.0 whole transcriptome data of 153 colonic biopsy samples (49 healthy adult, 49 adenoma, 49 CRC, 6 healthy children) (GEO accession numbers: GSE37364, GSE10714, GSE4183, GSE37267). Whole promoter methylation analysis of genes showing inverse DNA methylation-gene expression data was performed on 30 colonic samples using methyl capture sequencing. RESULTS Fifty-seven age-related CpG sites including hypermethylated PPP1R16B, SFRP1, SYNE1 and hypomethylated MGP, PIPOX were differentially methylated between CRC and normal tissues (P < 0.05, Δβ ≥ 10%). In the adenoma vs normal comparison, 70 CpG sites differed significantly, including hypermethylated DKK3, SDC2, SFRP1, SYNE1 and hypomethylated CEMIP, SPATA18 (P < 0.05, Δβ ≥ 10%). In MS-HRM analysis, the SFRP1 promoter region was significantly hypermethylated in CRC (55.0% ± 8.4 %) and adenoma tissue samples (49.9% ± 18.1%) compared to normal adult (5.2% ± 2.7%) and young (2.2% ± 0.7%) colonic tissue (P < 0.0001). DNA methylation of SFRP1 promoter was slightly, but significantly increased in healthy adults compared to normal young samples (P < 0.02). This correlated with significantly increased SFRP1 mRNA levels in children compared to normal adult samples (P < 0.05). In CRC tissue the mRNA expression of 117 age-related genes were changed, while in adenoma samples 102 genes showed differential expression compared with normal colonic tissue (P < 0.05, logFC > 0.5). The change of expression for several genes including SYNE1, CLEC3B, LTBP3 and SFRP1, followed the same pattern in aging and carcinogenesis, though not for all genes (e.g., MGP). CONCLUSION Several age-related DNA methylation alterations can be observed during CRC development and progression affecting the mRNA expression of certain CRC- and adenoma-related key control genes.

[1]  I. Csabai,et al.  Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer , 2016, Epigenetics.

[2]  S. Knuutila,et al.  The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription , 2016, Gastroenterology research and practice.

[3]  K. Kaestner,et al.  DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation , 2016, Cancer Prevention Research.

[4]  A. Kalmár,et al.  DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer , 2015, BMC Cancer.

[5]  Jill S Barnholtz-Sloan,et al.  Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival , 2015, Oncotarget.

[6]  Suman Lee,et al.  Epigenetic instability of imprinted genes in human cancers , 2015, Nucleic acids research.

[7]  A. Kalmár,et al.  Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas , 2015, PloS one.

[8]  A. Kalmár,et al.  Bisulfite-Based DNA Methylation Analysis from Recent and Archived Formalin-Fixed, Paraffin Embedded Colorectal Tissue Samples , 2015, Pathology & Oncology Research.

[9]  K. Shroyer,et al.  Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP) , 2015, Oncotarget.

[10]  M. Kobor,et al.  DNA methylation and healthy human aging , 2015, Aging cell.

[11]  D. Kerr,et al.  Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer , 2015, Oncoscience.

[12]  G. Pfeifer,et al.  Aging and DNA methylation , 2015, BMC Biology.

[13]  Nita Ahuja,et al.  Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood , 2014, Cancer Prevention Research.

[14]  Sangsoo Kim,et al.  In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers , 2014, Genomics & informatics.

[15]  S. Tavaré,et al.  Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists , 2014, BMC Cancer.

[16]  A. Kalmár,et al.  Myofibroblast-Derived SFRP1 as Potential Inhibitor of Colorectal Carcinoma Field Effect , 2014, PloS one.

[17]  A. Toker,et al.  Signalling specificity in the Akt pathway in breast cancer. , 2014, Biochemical Society transactions.

[18]  C. Ulrich,et al.  Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. , 2014, Gastroenterology.

[19]  S. Wingren,et al.  Whole genome DNA methylation signature of HER2-positive breast cancer , 2014, Epigenetics.

[20]  Sun-Hwa Park,et al.  Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells , 2014, BMC Cancer.

[21]  A. Forbes,et al.  FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia , 2014, Inflammatory bowel diseases.

[22]  R. Schoen,et al.  Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age , 2014, Epigenetics.

[23]  Mei-Lyn Ong,et al.  Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways , 2013, Aging cell.

[24]  Lawrence C. LaPointe,et al.  A panel of genes methylated with high frequency in colorectal cancer , 2014, BMC Cancer.

[25]  D. Amadori,et al.  Gene methylation in rectal cancer: Predictive marker of response to chemoradiotherapy? , 2013, Journal of cellular physiology.

[26]  S. Horvath DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[27]  Jacqueline Miranda de Lima,et al.  DNA methylation as an epigenetic biomarker in colorectal cancer , 2013, Oncology letters.

[28]  A. Kalmár,et al.  Sporadic Colorectal Cancer Development Shows Rejuvenescence Regarding Epithelial Proliferation and Apoptosis , 2013, PloS one.

[29]  M. Brattain,et al.  Cell survival and metastasis regulation by Akt signaling in colorectal cancer. , 2013, Cellular signalling.

[30]  M. Okoniewski,et al.  Early Insights into the Function of KIAA1199, a Markedly Overexpressed Protein in Human Colorectal Tumors , 2013, PloS one.

[31]  V. Govorun,et al.  Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips , 2013, Epigenetics.

[32]  H. Chung,et al.  Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. , 2013, The Journal of molecular diagnostics : JMD.

[33]  So Hyun Kim,et al.  The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin. , 2013, Biochemical and biophysical research communications.

[34]  Dong Kyung Chang,et al.  Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation , 2013, BMC Cancer.

[35]  A. Kalmár,et al.  Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples , 2012, PloS one.

[36]  H. Schulten,et al.  Methylation of the Polycomb Group Target Genes Is a Possible Biomarker for Favorable Prognosis in Colorectal Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[37]  B. Christensen,et al.  Key epigenetic changes associated with lung cancer development , 2012, Epigenetics.

[38]  K. D. Sørensen,et al.  Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas , 2011, International journal of cancer.

[39]  T. Ørntoft,et al.  Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells , 2011, British Journal of Cancer.

[40]  A. Sameer,et al.  Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population , 2011, Human Genomics.

[41]  Jun Yu,et al.  Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer , 2010, Oncogene.

[42]  B. Korn,et al.  Aging and Chronic Sun Exposure Cause Distinct Epigenetic Changes in Human Skin , 2010, PLoS genetics.

[43]  Y. Hu,et al.  DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer , 2010, Oncogene.

[44]  B. Molnár,et al.  Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor , 2010, British Journal of Cancer.

[45]  Edward L. Lee,et al.  Distinct High-Profile Methylated Genes in Colorectal Cancer , 2009, PloS one.

[46]  Jung Weon Lee,et al.  Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2. , 2009, Biochemical and biophysical research communications.

[47]  J. Herman,et al.  GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer , 2009, Clinical Cancer Research.

[48]  S. Toyooka,et al.  Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy. , 2008, Clinical biochemistry.

[49]  Zsolt Tulassay,et al.  Diagnostic mRNA Expression Patterns of Inflamed, Benign, and Malignant Colorectal Biopsy Specimen and their Correlation with Peripheral Blood Results , 2008, Cancer Epidemiology Biomarkers & Prevention.

[50]  Zsolt Tulassay,et al.  Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature , 2008, Disease markers.

[51]  J. Mathers,et al.  Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa , 2008, British Journal of Cancer.

[52]  Kohzoh Imai,et al.  Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. , 2007, Carcinogenesis.

[53]  Michal A. Kurowski,et al.  Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.

[54]  Manuel Serrano,et al.  The common biology of cancer and ageing , 2007, Nature.

[55]  P. Malfertheiner,et al.  Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. , 2005, Neoplasia.

[56]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.